How Strong Is AbbVie's Immunology Franchise After Humira's LOE?
unknown
📅 Published: 2025-12-04 12:39
📰 Source: Yahoo
📝 Words: 16
📝 Article Content
ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.
📄 Summary
ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2025-12-11 18:38:38
Updated At:
2025-12-11 18:38:38
Scraping Job ID:
N/A
Stock Mentions:
ABBV - AbbVie Inc.
Relevance: N/A